1 / 11

Epigenetics of Celiac Disease

Epigenetics of Celiac Disease. MEDICEL Malta 2011. Why this project?. Epigenetics is the first level of integration of genetic and environmental factors. It may translate the effects of risk factors in terms of molecular events.

sanne
Télécharger la présentation

Epigenetics of Celiac Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Epigenetics of Celiac Disease MEDICEL Malta 2011

  2. Why this project? • Epigenetics is the first level of integration of genetic and environmental factors. • It may translate the effects of risk factors in terms of molecular events. • It is feasable with the recent development of micro arrays/Si RNA knowledge. • There is no data published to date on this topic (pubmed september 2011).

  3. What is epigenetics? • Epigenetics is the a way to transmit gene regulatory signals through mitosis. It is required for maintenance of cell differentiation. • It is based on • DNA methylation • Histone acetylation and phosphorylation • RNA silencing

  4. Histone acetylation

  5. DNA methylation

  6. RNA silencing

  7. Epigenetics and complex diseases • Epigenetics is the reflect of • Environmental factors • Stochastic events • Aging • It is less stable than DNA variations but it is stable enough to explain chronic diseases. It may add to or reverse the effect of DNA variations explaining uncomplete penetrances. • It may explain • Altered sex ratio in complex diseases • Incomplete concordance in monozygotic twins • Cancers Ptak et al. 2008

  8. Key questions • To describe the epigenome of CD (DNA methylation and Si RNA expression). • To integrate this information with genetic and environmental data (disease modeling). • To provide disease associated biomarkers (predictive markers?).

  9. Study design • 500 CD and 500 controls • Data collection: • Clinical data • Environmental factors • Biobanquing • Blood (stored at 20°C) • Intestinal biopsies (stored at -20°C). • Intestinal biopsies (stored at -80°C in RNA later) for few centres.

  10. Procedures design • Genetic profiling of participants for the 30 known CD polymorphisms. • DNA methylation (Illumina 450k arrays) on blood and intestinal samples. • RNA analyses (siRNA and functional validation of DNA methylation data for the most relevant genes). • Biostatistics/ Mathematical modeling.

  11. Main deliverables/perspectives • A set of epigenetic biomarkers associated with the disease to be tested in prospective studies. • A comprehensive model of gene/environment integration at the epigenetic level.

More Related